Zusammenfassung
Einleitung
Ziel unserer Studie war es, einen Unterschied in der Expression der Corticotropin Releasing Hormon Rezeptoren R1/2 und R2 im Myometrium von Frauen mit Frühgeburten oder am Termin entbundener Kinder, mit oder ohne Wehentätigkeit der Mutter, zu bestimmen.
Material, Patienten und Methode
Bei insgesamt 40 Patientinnen, die per Kaiserschnitt entbunden hatten, wurde Myometrium gewonnen. Im Material von jeweils 10 Patientinnen, die Frühgeburten oder reife Kinder, mit oder ohne Wehentätigkeit, zur Welt brachten, wurde die immunhistochemische Expression mit Hilfe zweier Antikörper gegen CRH-R1/2 und CRH-R2 durchgeführt. Die Beurteilung erfolgte durch histologische Begutachtung von 3 unabhängigen Personen.
Resultate
Bei Frauen am Termin ohne Wehentätigkeit konnte ein Expression des CRH-R2 festgestellt werden. Bei jenen mit Wehen am Termin konnte in 8 von 10 Fällen keine Expression nachgewiesen werden. Im Myometrium der Frauen die Frühgeburten entbunden hatten, zeigte sich kein Unterschied in der Expression des CRH-R2. Der CRH-R1/2 Rezeptor wurde generell in allen vier Gruppen in der gleichen Intensität exprimiert.
Zusammenfassung
Die ausgeprägte Expression des CRH-R2 Rezeptors im Myometrium von Frauen am Termin vor Beginn, verbunden mit der Abnahme der Expression unter der Wehentätigkeit, könnte ein weiterer Hinweis der zentralen Rolle des Corticotropin Releasing Hormon in der Entstehung der Wehentätigkeit sein.
Summary
Objective
To determine differences in expression of corticotropin-releasing hormone receptors R1 and R2 in the myometrium of women delivering preterm or at term, with or without labor.
Material and methods
Small pieces of myometrial smooth muscle were taken from forty patients undergoing caesarian section. One sample each was taken from all preterm and term patients, with and without labor. Antibodies against CRH-R1/2 and CRH-R2 were used for localization by conventional fluorescence immunohistochemistry. The evaluation of staining was based on examination of the entire histologic section by three independent observers.
Results
In women at term, CRH-R2 levels were elevated before labor and decreased with the onset of labor. In eight of 10 term samples from women in labor, no staining was detected. In preterm patients we found no difference in CRH-R2 staining between women with and without labor. The intensity of staining for CRH-R1/2 was generally uniform in all four groups.
Conclusion
The high level of CRH-R2 expression in term patients without labor, together with the subsequent decrease of CRH-R2 in the myometrium during progression of labor, is consistent with the possibility that CRH may have autocrine/paracrine effects on myometrial contractility in the lower segment of the uterus.
References
Fuchs A, Fuchs F, Husslein P, Soloff M, Fernstrom M (1982) Oxitocin receptors and human parturition: a dual role for oxitocin in the initiation of labour. Science 215: 1396–1368
Karim S, Hillier K, Trusell R, Patel R, Tamusange S (1970) Induction of labour with prostaglandin E2. J Obstet Gynaecol Br Comonw 77: 200–210
McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R (1995) A placental clock controlling the length of human pregnancy. Nat Med 1: 40–43
Karalis K, Goodwin G, Majzoub JA (1996) Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor. Nat Med 2: 556–560
Reis FM, Fadalti M, Florio P, Petraglia F (1999) Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition. J Soc Gynecol Investig 6: 109–119
Smith R, Mesiano S, Cheng-Chan E, Brown S (1998) Corticotropin-releasing-hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrin Metab 83: 2916–2920
Grammatopoulos D, Dai Y, Chen J, Karteris E, Papadopoulou N, Easton A, Hillhouse E (1998) Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometrium. J Clin Endocrinol Metab 83: 2539–2544
Hillhouse E, Grammatopoulos D, Milton N, Quartero H (1993) The identification of a myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J Clin Endocrinol Metab 76: 736–741
Rodriguez-Linares B, Linton E, Phaneuf S (1998) Expression of corticotropin-releasing hormone receptor mRNA and protein in the human myometrium. J Endocrinol 156: 15–21
Stevens M, Challis J, Lye S (1998) Corticotropin-releasing hormone receptor subtype 1 is significantly up-regulated at the time of labor in human myometrium. J Clin Endocrinol Metab 83: 4107–4115
Jirecek S, Tringler B, Knöfler M, Bauer S, Topcuoglu A, Egarter C (2002) Redistribution of corticotropin-releasing hormone receptor R2 using fluorescence immunohistochemistry in fetal membranes of women delivering preterm or at term. Wien Klin Wochenschr 114: 1008–1012
Jain V, Longo M, Ali M, Saade GR, Chwalisz K, Garfield RE (2000) Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J Soc Gynecol Invest 7: 153–160
Clifton V, Telfer J, Thompson A, Cameron I, Teoh T, Lye S, Challis J (1998) Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium. J Clin Endocrinol Metab 83: 3716–3721
Petraglia F, Tabanelli S, Galassi M, Garuti G, Mancini A, Gurpide E (1992) Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. J Clin Endocrinol Metab 74: 1427–1431
Helmer H, Hackl T, Schneeberger C, Knoefler M, Behrens O, Kaider A, Husslein P (1998) Oxytocin and vasopressin 1a receptor gene expression in the cycling or pregnant human uterus. Am J Obstet Gynecol 179 (6 Pt 1): 1572–1578
Rauk PN, Friebe-Hoffmann U (2000) Interleukin-1 beta down-regulates the oxytocin receptor in cultured uterine smooth muscle cells. Am J Reprod Immunol 43: 85–91
Quartero H, Fry C (1989) Placental corticotropin releasing factor may modulate human parturition. Placenta 10: 439–443
Benedetto C, Petraglia F, Marozio L, Florio P, Massobrio M (1994) Corticotropinreleasing hormone increases prostaglandin 2α activity on human myometrium in vitro. Am J Obstet Gynecol 171: 126–131
McLean M, Thompson D, Zhang H, Brinsmead M, Smith R (1994) Corticotropinreleasing hormone and beta-endorphin in labour. Eur J Endocrinol 131: 167–172
Aggelidou E, Hillhouse EW, Grammatopoulos DK (2002) Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proc Natl Acad Sci USA 99: 3300–3305
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jirecek, S., Tringler, B., Knöfler, M. et al. Detection of corticotropin-releasing hormone receptors R1 and R2 (CRH-R1, CRH-R2) using fluorescence immunohistochemistry in the myometrium of women delivering pretern or at term. Wien Klin Wochenschr 115, 724–727 (2003). https://doi.org/10.1007/BF03040890
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03040890